Subspecialty	Cardiology
Clinical Interests	Cardiac Diseases
	Cardiac Testing and Treatment
	Cardiology
	Cardiopulmonary Disease
	Cardiovascular Disease
	Congestive Heart Failure
	Diastolic Dysfunction
	Heart Failure
	Heart Transplant
	Valvular Heart Disease
Languages	English
Gender	Male
E-mail	sean.pinney@mssm.edu
Education and Training	MD, Georgetown Univ. School of Medicine
	Chief Residency, Beth Israel Deaconess Hospital
	Residency, Internal Medicine, Beth Israel Deaconess Medical Center
	Internship, Internal Medicine, Beth Israel Deaconess Medical Center
	Fellowship, Cardiology, Columbia-Presbyterian Medical Center
	Fellowship, Cardiology, Columbia University

Dr. Pinney serves as Director of the Advanced Heart Failure and Cardiac Transplant Program at Mount Sinai Medical Center, and as Director of the Pulmonary Hypertension Program.

His clinical interests center upon the care of a broad spectrum of patients with advanced cardiovascular disease. These include patients with heart failure in need of heart transplantation or mechanical circulatory support devices; patients with pulmonary hypertension; and patients with congenital heart disease, in particular those in need of organ transplantation including combined heart-lung transplant.

Dr. Pinney is an active clinical researcher whose primary focus is the understanding and treatment of cardiac allograft vasculopathy. This condition affects approximately half of all transplant recipients by their fifth year and limits the long-term success of heart transplantation. He is the author of more than 20 publications in peer-reviewed journals and is frequent lecturer on the topic of cardiovascular disease.

He received his medical degree from Georgetown University and completed a residency and chief residency in internal medicine at Beth Israel Deaconess Hospital in Boston. He spent six years at Columbia University where he completed fellowships in cardiology, heart failure and cardiac transplantation before joining the faculty in the Division of Circulatory Physiology. He moved to Mount Sinai in 2004.

Education and Training	MD, Georgetown Univ. School of Medicine
	Chief Residency, Beth Israel Deaconess Hospital
	Residency, Internal Medicine, Beth Israel Deaconess Medical Center
	Internship, Internal Medicine, Beth Israel Deaconess Medical Center
	Fellowship, Cardiology, Columbia-Presbyterian Medical Center
	Fellowship, Cardiology, Columbia University

Subspecialty	Cardiology
Clinical Interests	Cardiac Diseases
	Cardiac Testing and Treatment
	Cardiology
	Cardiopulmonary Disease
	Cardiovascular Disease
	Congestive Heart Failure
	Diastolic Dysfunction
	Heart Failure
	Heart Transplant
	Valvular Heart Disease
Languages	English

Nagarsheth NP, Pinney S, Bassily-Marcus A, Anyanwu A, Friedman L, Beilin Y. Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Anesth Analg 2008; 107: 962-964.

Anyanwu AC, Fischer GW, Plotkina I, Pinney S, Adams DH. Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy. Ann Thorac Surg 2007; 84: 1405-1407.

Lubitz SA, Pinney S, Wisnivesky JP, Gass A, Baran DA. Statin therapy is associated with a reduced risk of chronic renal failure after cardiac transplantation. J Heart Lung Transplant 2007; 26: 264-272.

Winslow RD, Pinney S, Fuster V. Impact of implantable cardioverter-defibrillator trials on clinical management of patients with heart failure. Nat Clin Pract Cardiovasc Med 2006; 3: 86-93.

Salzberg SP, Filsoufi F, Anyanwu A, von Harbou K, Gass A, Pinney SP, Carpentier A, Adams DH. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80: 502-506.

Mckay M, Pinney S, Gorwara S, Burke EM, Sciacca RR, Apfelbaum M, Mancini D, Itescu S, Rabbani LE. Anti-HLA antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation 2005; 79: 1581-1587.

Pinney S, Cheema FH, Hammond K, Chen JM, Edwards NM, Mancini D. Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. J Heart Lung Transplant 2005; 24: 34-37.

Pinney SP, Mancini D. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention and treatment. Curr Opin Cardiol 2004; 19: 170-176.

Mancini DM, Pinney SP, Burkhoff D, Lamanca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108: 48-53.

Pinney SP, Chen HJ, Liang D, Wang X, Schwartz A, Rabbani LE. Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury.. J Cardiovasc Pharmacol 2003; 42: 469-476.